Saturday, August 30, 2014 Last update: 10:03 AM
FreshNews.com - All Company Technology News Since 1996

Agilux Laboratories Appoints Dr. Richard LeLacheur as Head of GLP Bioanalysis for Its Bioanalytical Operations

Companies mentioned in this article: Agilux Laboratories Inc.

WORCESTER, Mass. -- (BUSINESS WIRE) -- Agilux Laboratories, a leading provider of Drug Metabolism and Pharmacokinetics (DMPK) services to pharmaceutical and biotechnology firms, announced today that it has appointed Richard M. LeLacheur, Ph.D. to Head of GLP Bioanalysis for its pharmaceutical development services. Rich joined Agilux in early 2012 as Senior Director, Bioanalytical Operations and has also served as a member of its senior management team since that time. In his new role, Rich will be directly responsible for driving the scientific, regulatory and operational processes and improvements within its GLP bioanalytical labs.

For nearly two decades, Rich’s focus has been in regulated bioanalysis, where he has held positions of increasing operational responsibility at notable contract research organizations. Rich is an active member of the Global Bioanalytical Consortium harmonization team for small molecule bioanalysis and is a noted speaker and instructor on bioanalytical mass spectrometry throughout North America, Europe, Japan, and China. He also continues to serve as the founder and co-instructor for the High Resolution Mass Spectrometry short course at the American Society for Mass Spectrometry annual meeting.

“Rich has brought vast knowledge and GLP bioanalytical expertise to our team here at Agilux and has been instrumental in driving our scientific, regulatory and operational process improvements to enable first-class bioanalytical services,” said Jim Jersey, President and CEO. “We look forward to his future contributions and regulatory insight in this new role, and fully expect his dynamic efforts to further advance our range of GLP services for our clients.”

About Agilux Laboratories Inc.

Agilux Laboratories Inc., with over 90 employees and greater than 50,000 square feet of facility space, is a leading New England-based contract research organization (CRO) that has developed into one of the fastest growing CRO’s in the Boston/Cambridge biotech arena. Agilux Labs is driven by its ability to offer “Better Data Faster” across a broad range of services supporting drug discovery, pre-clinical and clinical services. Our full range of Drug Metabolism and Pharmacokinetic services, include fit-for-purpose rapid turnaround LC-MS/MS Bioanalysis, In-Vivo PK, and In-Vitro Assay services. With corresponding clinical site support, GLP LC-MS/MS Bioanalytical services are also provided to support regulated pre-clinical and clinical studies. To learn more, please visit us at www.agiluxlabs.com.


Copyright © Business Wire 2014
Contact:

Agilux Laboratories Inc.
Steve Guyan, MS, 508-753-5000
Vice President, Sales and Marketing
Fax: 508-630-1679
marketing@agiluxlabs.com